Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$504M |
| 2 |
Cigna
CI
|
+$469M |
| 3 |
Intuitive Surgical
ISRG
|
+$392M |
| 4 |
Procter & Gamble
PG
|
+$387M |
| 5 |
Parker-Hannifin
PH
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$357M |
| 2 |
Adeia
ADEA
|
+$356M |
| 3 |
Target
TGT
|
+$346M |
| 4 |
Salesforce
CRM
|
+$344M |
| 5 |
Eli Lilly
LLY
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 12.51% |
| 3 | Financials | 11.68% |
| 4 | Industrials | 8.82% |
| 5 | Consumer Discretionary | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
MKS Inc
MKSI
$22.1B
| $23.6M | 0.01% |
277,930
+22,258
| +9% | +$1.78M |
|
|
MAXR
1127
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $23.5M | 0.01% |
455,124
-175,601
| -28% | -$4.82M |
|
1128
Carlisle Companies
CSL
$15.1B
| $23.5M | 0.01% |
99,784
+27
| +0% | +$6.95K |
|
1129
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.02B
| $23.4M | 0.01% |
820,414
+252,010
| +44% | +$7.21M |
|
|
ISEE
1130
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $23.4M | 0.01% |
1,093,178
+850,515
| +350% | +$18.2M |
|
|
BSCP
1131
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
| $23.3M | 0.01% |
1,160,769
+255,641
| +28% | +$5.13M |
|
1132
iShares MSCI Australia ETF
EWA
$1.44B
| $23.3M | 0.01% |
1,048,555
+494,567
| +89% | +$10.8M |
|
1133
Fidelity MSCI Health Care Index ETF
FHLC
$3.28B
| $23.2M | 0.01% |
363,449
+113,792
| +46% | +$7.11M |
|
1134
Performance Food Group
PFGC
$17.8B
| $23.2M | 0.01% |
397,381
-36,098
| -8% | -$1.97M |
|
1135
ProShares Russell 2000 Dividend Growers ETF
SMDV
$711M
| $23.2M | 0.01% |
377,106
+7,837
| +2% | +$483K |
|
1136
Urban Outfitters
URBN
$6.72B
| $23.2M | 0.01% |
971,567
-58,473
| -6% | -$1.46M |
|
1137
Invesco S&P MidCap Low Volatility ETF
XMLV
$751M
| $23.1M | 0.01% |
431,206
-3,779
| -0.9% | -$199K |
|
|
CYBR
1138
DELISTED
CyberArk
CYBR
| $23.1M | 0.01% |
177,889
+1,213
| +0.7% | +$175K |
|
1139
iShares MSCI USA Value Factor ETF
VLUE
$9.47B
| $22.9M | 0.01% |
251,441
-149,909
| -37% | -$13.7M |
|
|
AEL
1140
DELISTED
American Equity Investment Life Holding Company
AEL
| $22.9M | 0.01% |
501,547
-453,804
| -48% | -$18.3M |
|
1141
MDU Resources
MDU
$4.21B
| $22.8M | 0.01% |
1,980,030
-53,731
| -3% | -$604K |
|
1142
iShares Russell 2000 Growth ETF
IWO
$15B
| $22.8M | 0.01% |
106,236
-21,010
| -17% | -$4.6M |
|
1143
Pan American Silver
PAAS
$19.1B
| $22.7M | 0.01% |
1,389,056
+532,813
| +62% | +$8.52M |
|
1144
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.23B
| $22.7M | 0.01% |
632,478
-83,411
| -12% | -$3.16M |
|
1145
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
| $22.6M | 0.01% |
265,952
-632,401
| -70% | -$52.3M |
|
1146
Nuveen ESG Small-Cap ETF
NUSC
$1.34B
| $22.6M | 0.01% |
662,046
+109,034
| +20% | +$3.8M |
|
1147
XPEL
XPEL
$1.28B
| $22.6M | 0.01% |
376,625
-112,087
| -23% | -$7.16M |
|
1148
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.84B
| $22.6M | 0.01% |
967,037
+233,266
| +32% | +$5.41M |
|
|
HI
1149
DELISTED
Hillenbrand
HI
| $22.6M | 0.01% |
529,100
-37,490
| -7% | -$1.66M |
|
1150
ResMed
RMD
$32B
| $22.6M | 0.01% |
108,405
-24,110
| -18% | -$5.3M |
|
Similar funds
Ameriprise's Q4 2022 Portfolio in Review
As of Q4 2022, Ameriprise held 4,135 positions worth $292B, up 7.9% from $270B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Ameriprise's Q4 2022 filing shows 152 new, 1,522 increased, 2,111 reduced and 185 closed positions. Its largest new stake was Abcam PLC: 5,014,378 shares worth $78M. The largest sale was CVS Health, an estimated $357M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2022 buy was Abcam PLC: 5,014,378 shares worth $78M.
- Ameriprise added most to Prologis in Q4 2022, an estimated $504M increase.
- Ameriprise's biggest Q4 2022 reduction was CVS Health, cutting an estimated $357M.
- Ameriprise fully exited Duke Realty Corp. in Q4 2022, selling an estimated $166M.
- Ameriprise's ten largest holdings make up 13% of its $292B portfolio in Q4 2022.
- Ameriprise opened 152 new positions and closed 185 in Q4 2022.
- Ameriprise's portfolio value rose 7.9% quarter-over-quarter to $292B.
Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.